» Articles » PMID: 24762496

The Investigation of Changes in Proteins Expression (Apolipoprotein A1 and Albumin) in Malignant Astrocytoma Brain Tumor

Overview
Specialty Oncology
Date 2014 Apr 26
PMID 24762496
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Angiogenesis performs a critical role in the development of cancer. Angiogenesis research is a cutting-edge field in cancer research. Proteomics is a powerful tool in identifying multiple proteins that are altered following a neuropharacological intervention in a disease of the central nervous system. Diagnostic oncoproteomics is the application of proteomic techniques for the diagnosis of malignancies.

Materials And Methods: We extracted proteins of tumor and normal brain tissues and then evaluated the protein purity by Bradford test and spectrophotometery method. In this study, we separated proteins by two-dimensional (2D) gel electrophoresis method and the spots were then analyzed and compared using statistical data and specific software, after providing three-dimensional images of spots alteration. Spots were identified by pH isoelectric, molecular weights, and data banks.

Results: Simple statistical test were used to establish a putative hierarchy in which the change in protein level were ranked according a cutoff point with P < 0.05. Apolipoprotein A1 (apo A1) protein and albumin were consistently upregulated in astrocytoma brain tumors.

Conclusion: The vascular microenvironment of glioma play a major role in determining the pathophysiological character is tics of the tumor. apo A1 and albumin are very significant due to their functional consequences in glioma tumor growth, migration and angiogenesis.

Citing Articles

Comparative proteomic analysis of astrocytoma tissues from patients with and without seizures.

Khaosuwan T, Leetanaporn K, Choochuen P, Navakanitworakul R, Kaewborisutsakul A, Tunthanatip T Sci Rep. 2025; 15(1):3020.

PMID: 39849075 PMC: 11757708. DOI: 10.1038/s41598-025-87525-3.


Introducing Albumin and Interleukin 6 as Common Critical Dysregulated Proteins Between Migraine and Gliosarcoma.

Arjmand B, Mansouri V, Hamzeloo Moghadam M, Rezaei Tavirani S Basic Clin Neurosci. 2023; 14(2):185-191.

PMID: 38107530 PMC: 10719970. DOI: 10.32598/bcn.2021.1483.2.


Multiple Reaction Monitoring-Based Targeted Assays for the Validation of Protein Biomarkers in Brain Tumors.

Ghantasala S, Pai M, Biswas D, Gahoi N, Mukherjee S, Kp M Front Oncol. 2021; 11:548243.

PMID: 34055594 PMC: 8162214. DOI: 10.3389/fonc.2021.548243.


Low Expression of APOB mRNA or Its Hypermethylation Predicts Favorable Overall Survival in Patients with Low-Grade Glioma.

Han C, He Y, Chen L, Wang J, Jiao S, Xia X Onco Targets Ther. 2020; 13:7243-7255.

PMID: 32801753 PMC: 7394594. DOI: 10.2147/OTT.S257794.


Proteomic Advances in Glial Tumors through Mass Spectrometry Approaches.

Pirlog R, Susman S, Iuga C, Florian S Medicina (Kaunas). 2019; 55(8).

PMID: 31357616 PMC: 6722920. DOI: 10.3390/medicina55080412.